Molecular Imaging

Plus Therapeutics beefs up manufacturing with SpectronRx

By AuntMinnie.com staff writers

Partnership supports 2026 radiopharmaceutical supply goal.

April 27, 2026

ChatGPT matches nuclear medicine experts on FDG-PET/CT scans

By Will Morton

Models excelled on cases with well-defined metabolic patterns, such as in typical cases of Alzheimer's disease, yet were less accurate on complex cases.

April 24, 2026

TAG1, NRG Pallas to advance Pb-212 supply for cancer therapies

By AuntMinnie.com staff writers

TAG1 and NRG Pallas aim to develop access to lead-212 (Pb-212) for cancer drug development across Europe.

April 22, 2026

Ionetix raises $30M to scale radioisotope production

By AuntMinnie.com staff writers

The funding will support scaling up of radioisotope production as well as R&D efforts in nuclear energy, materials testing, and related areas.

April 21, 2026

FAPI-PET superior to FDG-PET in liver cancer

By Will Morton

The finding is from a prospective head-to-head comparison among 59 patients with suspicious lesions.

April 20, 2026

MITA PET Group rebrands, expands scope to theranostics

By AuntMinnie.com staff writers

The new name reflects an expanded focus beyond diagnostic radiopharmaceuticals to include theranostics.

April 20, 2026

Brain MRI, PET may predict who gains most from lifestyle interventions

By Kate Madden Yee

Brain MRI, PET could help identify which older adults are most likely to benefit from a structured lifestyle program.

April 20, 2026

FDG-PET predicts outcomes in metastatic breast cancer

By Will Morton

Patients without disease progression on FDG-PET scans 14 days after treatment had better progression-free and overall survival.

April 16, 2026

Type of cardiac imaging before revascularization has shifted sharply

By Kate Madden Yee

Demographic disparities reveal modality-specific patterns, "underscoring the need for targeted interventions," researchers wrote.

April 16, 2026

Telix doses first patient in glioblastoma trial

By AuntMinnie.com staff writers

The patient was dosed at Austin Health in Melbourne, Australia.

April 15, 2026

Telix and Regeneron enter $2.1B partnership

By AuntMinnie.com staff writers

Regeneron to enter targeted radiopharmaceuticals sphere.

April 14, 2026

ARRS: Do GLP-1 drugs confound FDG-PET imaging scans?

By Will Morton

No significant differences in FDG uptake were observed in the skeletal muscle, liver, blood pool, or abdominal fat following GLP-1 agonist therapy.

April 13, 2026

Page 1 of 625

Next Page